Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

742 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk factors for Barrett's esophagus: a case-control study.
Conio M, Filiberti R, Blanchi S, Ferraris R, Marchi S, Ravelli P, Lapertosa G, Iaquinto G, Sablich R, Gusmaroli R, Aste H, Giacosa A; Gruppo Operativo per lo Studio delle Precancerosi Esofagee (GOSPE). Conio M, et al. Among authors: marchi s. Int J Cancer. 2002 Jan 10;97(2):225-9. doi: 10.1002/ijc.1583. Int J Cancer. 2002. PMID: 11774268
Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study.
Conio M, Blanchi S, Lapertosa G, Ferraris R, Sablich R, Marchi S, D'Onofrio V, Lacchin T, Iaquinto G, Missale G, Ravelli P, Cestari R, Benedetti G, Macrì G, Fiocca R, Munizzi F, Filiberti R. Conio M, et al. Among authors: marchi s. Am J Gastroenterol. 2003 Sep;98(9):1931-9. doi: 10.1111/j.1572-0241.2003.07666.x. Am J Gastroenterol. 2003. PMID: 14499768
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett's oesophagus for 1 year.
de Bortoli N, Martinucci I, Piaggi P, Maltinti S, Bianchi G, Ciancia E, Gambaccini D, Lenzi F, Costa F, Leonardi G, Ricchiuti A, Mumolo MG, Bellini M, Blandizzi C, Marchi S. de Bortoli N, et al. Among authors: marchi s. Aliment Pharmacol Ther. 2011 May;33(9):1019-27. doi: 10.1111/j.1365-2036.2011.04616.x. Epub 2011 Mar 8. Aliment Pharmacol Ther. 2011. PMID: 21385192 Clinical Trial.
Ranitidine bismuth citrate with either clarithromycin 1 g/day or 1.5 g/day is equally effective in the eradication of H. pylori and healing of duodenal ulcer.
Dobrilla G, Di Matteo G, Dodero M, Fratton A, Iaquinto G, Loriga P, Marchi S, Marzio L, Muratori R, Pacini D, Saggioro A, Savarino V, Spinelli P, Zamboni G, Fina P, Tosatto R, Olivieri A. Dobrilla G, et al. Among authors: marchi s. Aliment Pharmacol Ther. 1998 Jan;12(1):63-8. doi: 10.1046/j.1365-2036.1998.00279.x. Aliment Pharmacol Ther. 1998. PMID: 9692703 Clinical Trial.
Barrett's esophagus in 2016: From pathophysiology to treatment.
Martinucci I, de Bortoli N, Russo S, Bertani L, Furnari M, Mokrowiecka A, Malecka-Panas E, Savarino V, Savarino E, Marchi S. Martinucci I, et al. Among authors: marchi s. World J Gastrointest Pharmacol Ther. 2016 May 6;7(2):190-206. doi: 10.4292/wjgpt.v7.i2.190. World J Gastrointest Pharmacol Ther. 2016. PMID: 27158534 Free PMC article. Review.
Alginate controls heartburn in patients with erosive and nonerosive reflux disease.
Savarino E, de Bortoli N, Zentilin P, Martinucci I, Bruzzone L, Furnari M, Marchi S, Savarino V. Savarino E, et al. Among authors: marchi s. World J Gastroenterol. 2012 Aug 28;18(32):4371-8. doi: 10.3748/wjg.v18.i32.4371. World J Gastroenterol. 2012. PMID: 22969201 Free PMC article. Clinical Trial.
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD.
de Bortoli N, Frazzoni L, Savarino EV, Frazzoni M, Martinucci I, Jania A, Tolone S, Scagliarini M, Bellini M, Marabotto E, Furnari M, Bodini G, Russo S, Bertani L, Natali V, Fuccio L, Savarino V, Blandizzi C, Marchi S. de Bortoli N, et al. Among authors: marchi s. Am J Gastroenterol. 2016 Dec;111(12):1711-1717. doi: 10.1038/ajg.2016.432. Epub 2016 Sep 20. Am J Gastroenterol. 2016. PMID: 27644732
Post-traumatic inflammatory pseudotumor of the esophagus.
Marchi S, Costa F, Mumolo MG, Bellini M, Ciancia E, Giusti P, Maltinti G. Marchi S, et al. Gastrointest Endosc. 2001 Sep;54(3):397-9. doi: 10.1067/mge.2001.116324. Gastrointest Endosc. 2001. PMID: 11522992 No abstract available.
Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: a comparative study.
de Bortoli N, Guidi G, Martinucci I, Savarino E, Imam H, Bertani L, Russo S, Franchi R, Macchia L, Furnari M, Ceccarelli L, Savarino V, Marchi S. de Bortoli N, et al. Among authors: marchi s. Dis Esophagus. 2016 Feb-Mar;29(2):197-204. doi: 10.1111/dote.12319. Epub 2014 Dec 17. Dis Esophagus. 2016. PMID: 25516110
742 results